Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study). [electronic resource]
- Atherosclerosis Jun 2000
- 429-36 p. digital
Adult Aged Bezafibrate--therapeutic use Biomarkers--blood Cholesterol, HDL--blood Cholesterol, LDL--blood Double-Blind Method Drug Therapy, Combination Fatty Acids, Monounsaturated--therapeutic use Female Fluvastatin Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Hyperlipoproteinemia Type V--blood Hypolipidemic Agents--therapeutic use Indoles--therapeutic use Male Middle Aged Safety Treatment Outcome Triglycerides--blood